Dashboard
Manage Tickers

HAE


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

haemonetics-announces-a-limited-market-release-of-its-vascade-mvp-xl-vascular-closure-device
Haemonetics Announces A Limited Market Rel...
06/18/2024 20:17:02

haemonetics-strategic-moves-poised-to-boost-margins-and-earnings-says-analyst
Haemonetics' Strategic Moves Poised To Boo...
06/12/2024 17:34:28

Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix anal...

this-mccormick-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-wednesday
This McCormick Analyst Is No Longer Bearis...
06/12/2024 13:45:38

needham-upgrades-haemonetics-to-buy-announces-112-price-target
Needham Upgrades Haemonetics to Buy, Annou...
06/12/2024 09:30:24

Needham analyst Mike Matson upgrades Haemonetics (NYSE:HAE) from Hold to Buy and announces $112 price target.

haemonetics-prices-upsized-private-placement-of-600m-of-250-convertible-senior-notes-due-2029
Haemonetics Prices Upsized Private Placeme...
05/23/2024 10:03:24

haemonetics-announced-525m-convertible-senior-notes-offering
Haemonetics Announced $525M Convertible Se...
05/21/2024 20:41:06

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 20:31:00

4-analysts-assess-haemonetics-what-you-need-to-know
4 Analysts Assess Haemonetics: What You Ne...
05/10/2024 17:01:10

jmp-securities-maintains-market-outperform-on-haemonetics-raises-price-target-to-125
JMP Securities Maintains Market Outperform...
05/10/2024 16:52:14

JMP Securities analyst David Turkaly maintains Haemonetics (NYSE:HAE) with a Market Outperform and raises the price target f...

barrington-research-maintains-outperform-on-haemonetics-raises-price-target-to-107
Barrington Research Maintains Outperform o...
05/10/2024 14:30:02

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target f...

needham-reiterates-hold-on-haemonetics
Needham Reiterates Hold on Haemonetics
05/10/2024 09:50:38

Needham analyst Mike Matson reiterates Haemonetics (NYSE:HAE) with a Hold.

haemonetics-expects-2024-revenue-growth-of-5-8-on-reported-basis-and-0-3-on-organic-basis
Haemonetics Expects 2024 Revenue Growth Of...
05/09/2024 10:59:52

haemonetics-expects-2024-adjusted-eps-of-445-475-versus-consensus-of-440
Haemonetics Expects 2024 Adjusted EPS Of $...
05/09/2024 10:58:40

haemonetics-q4-2024-adj-eps-090-beats-089-estimate-sales-343290m-beat-329113m-estimate
Haemonetics Q4 2024 Adj EPS $0.90 Beats $0...
05/09/2024 10:10:57

barrington-research-maintains-outperform-on-haemonetics-maintains-105-price-target
Barrington Research Maintains Outperform o...
04/12/2024 14:43:30

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price target.

haemonetics-received-510k-clearance-from-fda-for-teg-6s-hemostasis-analyzer-system-global-hemostasis-hn-assay-cartridge
Haemonetics Received 510(k) Clearance From...
04/04/2024 10:32:27

This new cartridge extends Haemonetics' TEG 6s viscoelastic testing capabilities to serve fully heparinized patients in adu...

haemonetics-agrees-to-acquire-attune-medical-for-an-upfront-cash-payment-of-160m-plus-additional-contingent-consideration-based-on-sales-growth-in-the-three-years
Haemonetics Agrees To Acquire Attune Medic...
03/05/2024 11:02:41

barrington-research-reiterates-outperform-on-haemonetics-maintains-105-price-target
Barrington Research Reiterates Outperform ...
02/13/2024 14:32:39

Barrington Research analyst Michael Petusky reiterates Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price tar...

haemonetics-expects-reported-and-organic-sales-growth-of-10-12-versus-8-10-expected-earlier
Haemonetics Expects Reported And Organic S...
02/08/2024 11:08:21

haemonetics-q3-adjusted-eps-104-beats-094-estimate-sales-33625m-beat-32029m-estimate
Haemonetics Q3 Adjusted EPS $1.04 Beats $0...
02/08/2024 11:02:17

Haemonetics (NYSE:HAE) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.94 by 10....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)